Hemofiltration Prevents Contrast-Induced Nephropathy
Wednesday, 08 March 2006
NEW YORK (Reuters Health) - Pre- and post-procedural hemofiltration appears to be the best means of preventing nephropathy caused by contrast medium administration in patients with chronic kidney disease, according to Italian researchers.
read more
|
Easing Kidney Donor Criteria Would Not Boost Available Organs Much
Monday, 27 February 2006
NEW YORK (Reuters Health) - Accepting living donors with mild hypertension or proteinuria for kidney transplants would lead to only a modest increase in transplantation rates, researchers report. Raising awareness among potential donors would have more impact, they say.
read more
|
Arterial Stiffness Associated With Renal Function In Kidney Donors
Tuesday, 21 February 2006
NEW YORK (Reuters Health) - In living kidney donors, pulse wave velocity and pulse pressure, indicators of arterial stiffness, are associated with renal factors, according to a report in the February issue of Hypertension.
read more
|
Selective Embolization Outcomes For Renal Angiomyolipomas In Tuberous Sclerosis Patients
Monday, 28 November 2005
BERKELEY, CA (UroToday.com) - Tuberous sclerosis complex (TSC) is an autosomal dominant disease of variable penetrance that clinically manifests with sebaceous adenoma, mental retardation and renal lesions.
read more
|
Long-Term Outcome Of Transcatheter Embolization Of Renal Angiomyolipomas Due To Tuberous Sclerosis Complex Proves Efficacy And Safety
Monday, 21 November 2005
BERKELEY, CA (UroToday.com) - Complications from renal angiomyolipomas (AMLs) are common in patients with tuberous sclerosis complex (TSC) and tumors greater than 4 cm are more likely to cause symptoms.
read more
|
Live Kidney-Paired Donations For Transplants May Increase Donor Pool
Wednesday, 05 October 2005
NEW YORK (Reuters Health) - A live kidney-paired donation (KPD) program at Johns Hopkins University substantially increased the number of compatible donor kidneys available for transplantation without compromising the quality of the donations, investigators report.
read more
|
New Agent May Improve Long-Term Renal Transplant Outcome
Thursday, 25 August 2005
NEW YORK (Reuters Health) - Treatment with belatacept, an experimental agent that selectively blocks T cell activation, is just as effective as cyclosporine in preventing acute rejection of renal grafts, but may have less long-term toxicity, new research suggests.
read more
|
Meta-Analysis: Low-Dose Dopamine Increases Urine Output but Does Not Prevent Renal Dysfunction or Death
Wednesday, 18 May 2005
BERKELEY, CA (UroToday Inc.) - "Renal dose" intravenous dopamine (< 5 mcg/kg/min) has been thought to improve urine output by increasing renal blood flow in patients at risk for acute renal failure.
read more
|
New Agent May Improve Organ Transplant Success
Wednesday, 02 March 2005
NEW YORK (Reuters Health) - The potent immunosuppressive properties of LEA29Y (belatacept) may offer longer allograft survival and lower toxicity than existing treatments do, according to animal studies reported in the March issue of the American Journal of Transplantation.
read more
|
Radical Prostatectomy in Renal Transplant Patients
Friday, 18 February 2005
BERKELEY, CA (UroToday Inc.) - Greater numbers of older men undergo renal transplantation; graft half-life has steadily climbed, so it is inevitable that urologists will see more of these patients who eventually develop prostate cancer.
read more
|
Egyptian Report on Risk Factors for Surgical Complications in Live-Donor Pediatric and Adolescent Renal Transplantation
Monday, 14 February 2005
BERKELEY, CA (UroToday Inc.) - Surgical complications represent the most common difficulties after pediatric renal transplantation and may be associated with the greatest morbidity.
read more
|
Angiotensin Receptor Antibodies Can Cause Renal Allograft Rejection
Monday, 14 February 2005
NEW YORK (Reuters Health) - Some patients with refractory vascular renal allograft rejection and accelerated hypertension have pathogenic antibodies directed at the angiotensin II type 1 (AT1) receptor, investigators report in the New England Journal of Medicine for February 10.
read more
|
Kidney Recipients at Higher Risk of De Novo Renal Cell Cancer in Native Kidneys
Wednesday, 02 February 2005
NEW YORK (Reuters Health) - Kidney transplant recipients appear to have an increased risk of de novo renal cell carcinoma in their native kidneys, according to a report in the January 15th issue of Cancer.
read more
|
Bioartificial Kidney Shows Promise as Treatment for Acute Renal Failure
Tuesday, 09 November 2004
NEW YORK (Reuters Health) - The initial findings from the first human trial of a bioartificial kidney suggest that the device can safely improve a variety of metabolic disturbances in patients with acute renal failure (ARF).
read more
|
EBV Reactivation May Be Linked to Kidney Transplant Rejection
Friday, 05 November 2004
NEW YORK (Reuters Health) - Reactivation of Epstein-Barr virus (EBV) may play a role in renal allograft rejection, according to German researchers.
read more
|
Renal Transplantation, Vascular Disease 
